Zai Lab Ltd share price logo

Zai Lab Ltd

NASDAQ: ZLAB

Mid Cap

$21.01

+0.03

(+0.14%)

as on

Zai Lab Ltd Stock Performance

as on May 7, 2026 at 6:18 pm IST

  • Day's Low

    Day's High

    $20.37
    $21.45
    downward going graph

    3.05%

    Downside

    2.09%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $15.96
    $44.34
    downward going graph

    24.04%

    Downside

    111.04%

    Upside

    downward going graph

Zai Lab Ltd share price movements today

Previous Close
$20.98
Open
$20.76
Volume
1.2M
Day's Low - High
$20.37 - $21.45
52 Week Low - High
$15.96 - $44.34

Zai Lab Ltd Historical Returns

1 Month Return
+ 0.05 %
3 Month Return
+ 16.72 %
1 Year Return
-25.92 %
3 Year Return
-44.2 %
5 Year Return
-86.71 %

Zai Lab Ltd Stock Fundamentals & Key Indicators

Check Zai Lab Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

-1.9808

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-214.4M

Revenue (TTM)

460.2M

Profit Margin

-38.15%

Return On Equity TTM

-22.56%

Zai Lab Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zai Lab Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.4B-86.71%NA-38.15%
BUY$40.5B130.77%76.3212.55%
BUY$108.5B98.9%25.3835.51%
NA$32.5BNA70.895.37%
BUY$75.6B45.15%17.629.65%

Stock Returns calculator for Zai Lab Ltd Stock including INR - Dollar returns

The Zai Lab Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Zai Lab Ltd investment value today

Current value as on today

₹83,139

Returns

-₹16,861

(-16.86%)

Returns from Zai Lab Ltd Stock

-₹25,917 (-25.92%)

Dollar Impact

₹9,056 (+9.06%)

Analyst Recommendation on Zai Lab Ltd Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Zai Lab Ltd. Average target price of $35.34

Zai Lab Ltd Share Price Target

Get share price movements and forecasts by analysts on Zai Lab Ltd.

What analysts predicted

40.55%UPSIDE

Target Price

$35.34

Current Price

$21.01

Analyzed by

12 Analysts

Target

$35.34

Zai Lab Ltd target price $35.34, a slight upside of 40.55% compared to current price of $21.01. According to 12 analysts rating.

Indian Investors' Interest in Zai Lab Ltd Stock

Search interest for Zai Lab Ltd Stock has increased by 21% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:21% versus previous 30 day period

Zai Lab Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
69
65
87
100
102
109
106
109
116
127
Gross Profit
43
40
53
65
65
66
67
66
69
65
Operating Income
-83
-123
-70
-76
-67
-67
-56
-54
-48
-69
EBITDA
-81
-119
-50
-76
-38
-75
-43
-35
-30
-48
Interest Expense
-
20
0
0
0
0
1
1
1
1
Depreciation
1
2
3
2
2
3
3
3
3
3
Income Before Tax
-69
-95
-53
-80
-41
-81
-48
-40
-35
-53
Income Tax Expense
-9
-21
9
-
-
-
-
-
-
-2
Net Income
-69
-95
-53
-80
-41
-81
-48
-40
-35
-50
Net Profit Margin
-99.89%
-144.96%
-61.36%
-79.87%
-40.75%
-74.89%
-45.49%
-37.03%
-30.98%
-39.51%

Zai Lab Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
0
12
48
144
215
266
398
460
Gross Profit
-
-
0
9
-190
92
141
170
251
269
Operating Income
-38
-51
-141
-203
-301
-700
-404
-366
-282
-229
EBITDA
-38
-50
-138
-199
-297
-689
-434
-365
-234
-158
Interest Expense
1
1
0
0
0
3
14
14
2
5
Depreciation
-
0
1
3
4
6
8
8
11
15
Income Before Tax
-37
-50
-138
-194
-268
-703
-443
-334
-257
-178
Income Tax Expense
1
0
3
-10
30
1
0
38
-
-2
Net Income
-37
-50
-139
-183
-268
-704
-443
-334
-257
-175
Net Profit Margin
0.00%
0.00%
-107433.56%
-1412.16%
-549.26%
-488.16%
-206.14%
-125.46%
-64.44%
-38.15%

Zai Lab Ltd Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-95
-53
-80
-41
-81
-48
-40
-35
-50
Operating Cash Flow
-14
-90
-42
-26
-55
-61
-31
-32
-26
Investing Cash Flow
14
3
0
-29
-347
326
-2
-4
-11
Financing Cash Flow
0
47
22
42
237
43
8
20
0
Change in Cash
0
-39
-20
-13
-166
307
-24
-15
-37

Zai Lab Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-50
-139
-195
-268
-704
-443
-334
-257
-175
Operating Cash Flow
-32
-97
-191
-216
-549
-367
-198
-214
-150
Investing Cash Flow
-10
-212
-14
-554
249
420
-10
-375
307
Financing Cash Flow
187
144
219
1,132
820
-1
-6
349
72
Change in Cash
145
-166
13
366
522
44
-218
-240
229

Global Institutional Holdings in Zai Lab Ltd

Funds
Holdings
ClearBridge Advisors, LLC
3.18%
Citadel Advisors Llc
1.5%
ADAR1 Capital Management LLC
1.11%
CAM Group Holding A/S
0.45%
BlackRock Inc
0.42%

Insights on Zai Lab Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 106.48M → 127.59M (in $), with an average increase of 5.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 28.1% return, outperforming this stock by 54.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 19.1% return, outperforming this stock by 63.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ZLAB stock has moved down by -3.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -35.96M → -50.40M (in $), with an average decrease of 40.2% per quarter

About Zai Lab Ltd

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. The company has a strategic collaboration with Tesaro, Inc., NovoCure Ltd., Deciphera Pharmaceuticals, LLC, Paratek Bermuda Ltd., argent BV, Turning Point Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Karuna Therapeutics, Inc., Pfizer Inc., Amgen Inc., and with Boehringer Ingelheim GmbH. The company was incorporated in 2013 and is based in Pudong, China.
OrganisationZai Lab Ltd
HeadquartersBuilding B, Pudong, China, 201203
IndustryBiotechnology
CEODr. Ying Du Ph.D.
E-voting on sharesClick here to vote

Key Management of Zai Lab Ltd

Name

Title

Dr. Ying Du Ph.D.

Founder, Chairperson & CEO

Dr. Rafael G. Amado M.D.

President and Head of Global Research & Development

Mr. Frazor Titus Edmondson III, J.D.

Chief Legal Officer & Corporate Secretary

Mr. Tong Zhu

Chief Commercial Officer of Greater China

Mr. Joshua L. Smiley

President & COO

Dr. Yajing Chen Ph.D.

Chief Financial Officer

Ms. Christine Chiou

Senior VP & Head of Investor Relations

Dr. James Yan DABT, M.D., Ph.D.

Chief Operating Officer of R&D

Dr. Shan He Ph.D.

Senior VP & Chief Business Officer

FAQs

What is Zai Lab Ltd share price today?

Zai Lab Ltd share price today is $21.01 as on at the close of the market. Zai Lab Ltd share today touched a day high of $21.45 and a low of $20.37.

What is the 52 week high and 52 week low for Zai Lab Ltd share?

Zai Lab Ltd share touched a 52 week high of $44.34 on and a 52 week low of $15.96 on . Zai Lab Ltd stock price today i.e. is closed at $21.01,which is 52.62% down from its 52 week high and 31.64% up from its 52 week low.

What is Zai Lab Ltd's market capitalisation today?

Zai Lab Ltd market capitalisation is $0.00T as on .

How to invest in Zai Lab Ltd Stock (ZLAB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zai Lab Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zai Lab Ltd Shares that will get you 0.0714 shares as per Zai Lab Ltd share price of $21.01 per share as on May 7, 2026 at 12:48 pm IST.

What is the minimum amount required to buy Zai Lab Ltd Stock (ZLAB) from India?

Indian investors can start investing in Zai Lab Ltd (ZLAB) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Zai Lab Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Zai Lab Ltd share’s latest price of $21.01 as on May 7, 2026 at 12:48 pm IST, you will get 0.4760 shares of Zai Lab Ltd. Learn more about fractional shares .

What are the returns that Zai Lab Ltd has given to Indian investors in the last 5 years?

Zai Lab Ltd stock has given -86.71% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?